Companies

Whitehawk Therapeutics, Inc.

WHWK · CIK 0001422142 · operating

$3.23-7.98%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$152.70M
P/E
Fwd P/E-2.81
PEG
P/S10.62
P/B0.97
EV/EBITDA0.09
EV/Rev-0.69

Profitability

Gross Margin
Op. Margin-259.62%
Net Margin-245.13%
ROE-121.37%
ROA-90.57%
FCF Margin-235.55%

Financial Health

Current Ratio3.59
Debt/Equity0.34
Free Cash Flow-$61.20M
Div. Yield

Growth & Other

Revenue Growth6.69%
EPS Growth3.28%
Beta0.69
52W High$3.77
52W Low$1.39

About Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc. (WHWK) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $156 million, Whitehawk Therapeutics, Inc. is a micro-cap company. The stock currently trades at $3.23, down 7.98% today, with a 52-week range of $1.39–$3.77.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-2.36$-2.36+3.3%
2023$-2.44$-2.44+9.3%
2022$-2.69$-2.69
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011

Annual Reports (10-K) · 17 filings

Report DateFiledAccession Number
2024-12-312025-03-280001628280-25-015269SEC ↗
2023-12-312024-03-130001628280-24-010901SEC ↗
2022-12-312023-03-290001628280-23-009583SEC ↗
2021-12-312022-03-170001564590-22-010721SEC ↗
2020-12-312021-03-110001564590-21-012252SEC ↗
2019-12-312020-03-160001564590-20-011174SEC ↗
2018-12-312019-03-070001564590-19-006602SEC ↗
2017-12-312018-03-150001564590-18-005868SEC ↗
2016-12-312017-03-070001213900-17-002066SEC ↗
2015-12-312016-03-300001213900-16-012024SEC ↗
2014-12-312015-02-270001213900-15-001427SEC ↗
2013-12-312014-03-310001213900-14-001894SEC ↗
2012-12-312013-03-280001144204-13-018033SEC ↗
2011-12-312012-03-300001144204-12-018750SEC ↗
2010-12-312011-03-310001144204-11-019031SEC ↗
2009-12-312010-03-310001144204-10-017288SEC ↗
2008-12-312009-03-310001144204-09-017635SEC ↗